As of 2025-12-15, the EV/EBITDA ratio of agilon health Inc (AGL) is -0.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AGL's latest enterprise value is 161.37 mil USD. AGL's TTM EBITDA according to its financial statements is -312.53 mil USD. Dividing these 2 quantities gives us the above AGL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 12.2x | 11.5x |
| Forward P/E multiples | 11.3x - 12.4x | 12.2x |
| Fair Price | (8.19) - (8.85) | (8.58) |
| Upside | -1238.9% - -1331.2% | -1294.0% |
| Date | EV/EBITDA |
| 2025-12-12 | -0.52 |
| 2025-12-11 | -0.52 |
| 2025-12-10 | -0.46 |
| 2025-12-09 | -0.44 |
| 2025-12-08 | -0.48 |
| 2025-12-05 | -0.43 |
| 2025-12-04 | -0.53 |
| 2025-12-03 | -0.46 |
| 2025-12-02 | -0.44 |
| 2025-12-01 | -0.39 |
| 2025-11-28 | -0.43 |
| 2025-11-26 | -0.44 |
| 2025-11-25 | -0.41 |
| 2025-11-24 | -0.41 |
| 2025-11-21 | -0.39 |
| 2025-11-20 | -0.26 |
| 2025-11-19 | -0.24 |
| 2025-11-18 | -0.29 |
| 2025-11-17 | -0.27 |
| 2025-11-14 | -0.33 |
| 2025-11-13 | -0.36 |
| 2025-11-12 | -0.40 |
| 2025-11-11 | -0.38 |
| 2025-11-10 | -0.44 |
| 2025-11-07 | -0.45 |
| 2025-11-06 | -0.49 |
| 2025-11-05 | -0.56 |
| 2025-11-04 | -0.52 |
| 2025-11-03 | -0.64 |
| 2025-10-31 | -0.62 |
| 2025-10-30 | -0.62 |
| 2025-10-29 | -0.71 |
| 2025-10-28 | -0.77 |
| 2025-10-27 | -0.82 |
| 2025-10-24 | -0.85 |
| 2025-10-23 | -0.87 |
| 2025-10-22 | -0.81 |
| 2025-10-21 | -0.81 |
| 2025-10-20 | -0.88 |
| 2025-10-17 | -0.84 |
| 2025-10-16 | -0.84 |
| 2025-10-15 | -0.92 |
| 2025-10-14 | -0.78 |
| 2025-10-13 | -0.74 |
| 2025-10-10 | -0.82 |
| 2025-10-09 | -0.92 |
| 2025-10-08 | -1.01 |
| 2025-10-07 | -0.97 |
| 2025-10-06 | -1.05 |
| 2025-10-03 | -1.06 |